David Hahn
Genentech, Inc., A Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080, USA
Articles
Risk-Based Predictive Stability–An Industry Perspective
Fenghe Qiu;Yan Wu;David Hahn;Megan McMahon;Rachel Orr;Debra Webb;Elke Debie;Lois Sechler;Helen Williams;Dennis Stephens;Cherokee Hoaglund Hyzer
March 2nd 2017A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 6th 2024 | Updated: November 20th 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 20th 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 20th 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
Published: November 4th 2024 | Updated: November 20th 2024
Strategies for Overcoming Common Challenges in Tech Transfer
